Retatrutide
Research OnlyTriple Agonist (GLP-1/GIP/Glucagon)
Retatrutide is a triple hormone receptor agonist that targets GLP-1, GIP, and Glucagon receptors. This multi-mechanism approach is designed to powerfully regulate appetite, improve insulin sensitivity, and increase energy expenditure, leading to significant weight management and metabolic benefits.
Dosing Schedule
| Week | Dose | Units (U-100) |
|---|---|---|
| 1-4 | 2 mg | 40 units |
| 5-8 | 4 mg | 80 units |
| 9-12 | 6 mg | 120 units |
| 13-16 | 9 mg | 180 units |
| 17-20 | 12 mg | 240 units |
Frequency: Inject once weekly subcutaneously.
When you BUY Retatrutide, you want to know that it's pure. We recommend using trusted suppliers for your research needs.
Visual representation of the dosage ramp-up over the cycle duration.
Reconstitution
2ml
5 mg/mL
10 mg
Add 2.0 mL bacteriostatic water to a 10mg vial for a concentration of 5 mg/mL.
Administration
Timing Strategy
Choose a convenient day of the week and administer at the same time each week.
Cycle Length
Titrate up every 4 weeks as tolerated. Maximum dose is 12mg weekly.
Research Benefits
Activates GLP-1, GIP, and Glucagon receptors to suppress appetite, enhance insulin secretion, and increase metabolic rate.
Storage Guidelines
Lyophilized: Store at -20°C (-4°F).
Reconstituted: Refrigerate at 2-8°C (36-46°F). Do not freeze.
Research Purposes Only
This information is for educational and research purposes only. These compounds are not approved for human consumption. Always consult with a qualified professional and adhere to local regulations regarding research chemicals.
Concentration
5.00 mg/mL
(5000 mcg/mL)
Injection Volume
0.05 mL
Draw to this mark on U-100 Syringe
Visual representation on a standard U-100 Insulin Syringe